Why FSH Remains Elevated in Postmenopausal Women on Testosterone and Progesterone
FSH remains elevated in postmenopausal women taking testosterone and progesterone because neither of these hormones provides adequate negative feedback to suppress pituitary FSH secretion—only estrogen effectively suppresses FSH in postmenopausal women.
The Physiological Mechanism
In postmenopause, FSH rises 10-15 fold above premenopausal levels due to loss of ovarian estradiol and inhibin production 1. The hypothalamic-pituitary-ovarian axis relies primarily on estradiol and inhibin as the key negative feedback regulators of FSH secretion 1, 2.
Why Progesterone Doesn't Suppress FSH
Progesterone alone does not provide meaningful negative feedback on FSH secretion. The evidence demonstrates:
- Progesterone with estrogen (not progesterone alone) is what modulates gonadotropin levels 3
- Studies show that when progesterone is combined with conjugated estrogens, FSH levels decrease, but this effect is attributable to the estrogen component 4
- The drug label for progesterone explicitly states it is used "in combination with estrogen-containing medications" for endometrial protection, not for FSH suppression 4
Why Testosterone Doesn't Suppress FSH
Testosterone similarly lacks the capacity to adequately suppress FSH in postmenopausal women:
- Testosterone does not bind to estrogen receptors in the pituitary with sufficient affinity to provide negative feedback
- While some peripheral conversion of testosterone to estradiol occurs via aromatase, this conversion is typically insufficient to meaningfully suppress FSH in the postmenopausal state
- The elevated FSH persists because the pituitary continues to sense the absence of adequate estradiol signaling
Clinical Context
The diagnosis of menopause should be based on clinical criteria (12 months of amenorrhea), not FSH levels 5. FSH measurement has limited clinical utility in postmenopausal women because:
- FSH levels show considerable variability and overlap across menopausal stages 6
- No single FSH cutoff value reliably distinguishes menopausal status 6
- The commonly cited FSH threshold of 40 IU/L is "inappropriate by itself for clinical determination of postmenopausal status" 6
Important Caveats
If this patient requires FSH suppression for a specific clinical indication, estrogen therapy would be necessary to achieve meaningful FSH reduction 7. The meta-analysis by 7 demonstrates that both oral and transdermal estrogen (but not vaginal estrogen) significantly reduce FSH levels in postmenopausal women.
The elevated FSH itself is not pathological—it simply reflects the normal postmenopausal state in the absence of estrogen replacement. Unless there is a specific clinical reason to suppress FSH (such as managing certain hormone-sensitive conditions), the elevated FSH on testosterone and progesterone therapy requires no intervention.